1295786

Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 2410662

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 17, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pearl River, NY (United States)

Citations

IDCFRDescription
145221 CFR 211.113(b)Validation lacking for sterile drug products
180321 CFR 211.84(b)Representative Samples Criteria
239921 CFR 211.194(a)(2)Laboratory Test Method Verification
432021 CFR 211.84(d)(6)Microbiological Contamination Exam